Inventor · disambiguated record
Ann-Marie Bullion
Also filed as: BULLION ANN · BULLION ANN M · BULLION ANN-MARIE
6 granted patents·4 pending applications·47 citations·filing 2003–2013
82Inventor score
Files withBAYER PHARMACEUTICALS CORP4BAYER IP GMBH2ANDERSON NIALL1BAYER HEALTHCARE LLC1HENTEMANN MARTIN1
Top patents by PatentIndex Score
10 records- 0187US8466283B2Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisHENTEMANN MARTIN·Filed 2007·Granted Jun 18, 2013·19 cites·47 claims
- 0286USRE46856ESubstituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2007·Granted May 22, 2018·9 cites·57 claims
- 0385US7678804B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER HEALTHCARE LLC·Filed 2005·Granted Mar 16, 2010·4 cites·11 claims
- 0479US8859572B2Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesisHENTEMANN MARTIN F·Filed 2009·Granted Oct 14, 2014·9 cites·16 claims
- 0570US7582645B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 1, 2009·4 cites·10 claims
- 0667US2010075967A1Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 0763US7265144B2Anilinopyrazole derivatives useful for the treatment of diabetesBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Sep 4, 2007·2 cites·40 claims
- 0853US2013261113A1Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 0953US2008064734A1Anilinopyrazole derivatives useful for the treatment of diabetesBAYER PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 1031US2012142668A1Cathepsin c inhibitorsANDERSON NIALL·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →